Department of Orthopedic Surgery, Kansas University Medical Center, 3901 Rainbow Blvd., Mail Stop 3017, Kansas City, KS 66160, USA.
Spine J. 2010 Jan;10(1):5-15. doi: 10.1016/j.spinee.2009.08.460. Epub 2009 Oct 12.
During the past 25 years, spinal instrumentation systems and surgical techniques used to treat idiopathic scoliosis have evolved, achieving fewer patient restrictions during arthrodesis healing, shorter constructs, and better correction. The purposes of this retrospective comparative study were to determine the survivorship of the implant/fusion without reoperation and the risk factors influencing such survival.
From 1989 through 2002, 208 consecutive patients (index patient included, age 10-20 years) underwent primary posterior instrumentation and arthrodesis with the same multiple anchor implant system by one surgeon, a co-designer of the system. Two hundred seven were followed for more than 2 years; reoperation status was available for them at an average follow-up of 8.3 years. Twenty-one independent demographic, deformity, instrumentation, and process variables possibly influencing the need for reoperation were studied by comparing the reoperated group with the unreoperated group.
Nineteen patients (9.2%) had reoperation; 16 (7.7%) were for indications related to posterior spine instrumentation. Survival of the implant/fusion without reoperation for spine instrumentation-related indications was 96% (95% confidence interval [CI], 93.2-98.7%) at 5 years, 91.6% (95% CI, 86.9-96.3%) at 10 years, 87.1% (95% CI, 79.5-94.6%) at 15 years, and 73.7% (95% CI, 48.6-98.6%) at 16 years, when the number at risk was nine. Reoperation need was significantly influenced by two implant variables: transverse connector design (p=.0012) and the lower instrumented vertebra anchors used (p=.0004). At 9 years, the longest interval allowing comparison, survival of the implant/fusion without reoperation for these two variables was 100% (six subjects at risk) compared to 82% (95% CI, 74.2-90.3%) with 59 patients still at risk for reoperation for those who did not have them, p=.0014.
The most stable lower instrumented vertebra anchor configuration, bilateral pedicle screws, and the stronger transverse connector design, closed drop entry, provided the best survival of the implant/fusion without reoperation with this system and the techniques used at 9-year follow-up. We hope that this post-market study using survivorship techniques will be a guide for studies of other spinal implants.
在过去的 25 年中,用于治疗特发性脊柱侧凸的脊柱器械系统和手术技术已经发展,在融合愈合过程中减少了患者的限制,缩短了器械的长度,并获得了更好的矫正效果。本回顾性比较研究的目的是确定无需再次手术的植入物/融合体的存活率以及影响这种存活率的危险因素。
1989 年至 2002 年,同一位外科医生(该系统的共同设计者)使用相同的多锚定植入物系统对 208 例连续患者(包括索引患者,年龄 10-20 岁)进行了初次后路器械固定和融合术。207 例患者随访时间超过 2 年;平均随访 8.3 年时,可获得他们的再次手术情况。通过比较再次手术组和未再次手术组,研究了 21 个可能影响再次手术需要的独立人口统计学、畸形、器械和手术过程变量。
19 例患者(9.2%)接受了再次手术;16 例(7.7%)是为了与后路脊柱器械相关的指征而进行的。5 年时,与脊柱器械相关的指征无关的植入物/融合体无需再次手术的存活率为 96%(95%置信区间[CI],93.2-98.7%),10 年时为 91.6%(95% CI,86.9-96.3%),15 年时为 87.1%(95% CI,79.5-94.6%),16 年时为 73.7%(95% CI,48.6-98.6%),此时风险人数为 9 人。再次手术的需要明显受到两个植入物变量的影响:横连接器设计(p=.0012)和使用的下固定椎骨锚定(p=.0004)。在 9 年的最长比较间隔中,这两个变量的植入物/融合体无需再次手术的存活率为 100%(6 例患者有风险),而未使用这些变量的患者的存活率为 82%(95% CI,74.2-90.3%),仍有 59 例患者有再次手术的风险,p=.0014。
使用该系统和技术进行 9 年随访时,最稳定的下固定椎骨锚定结构、双侧椎弓根螺钉和更强的横连接器设计(闭合式下入),为植入物/融合体无需再次手术提供了最佳的存活率。我们希望本研究使用生存分析技术能为其他脊柱植入物的研究提供指导。